HSRC - Frequently Asked Questions

All research, sponsored either directly or indirectly by the Health Care Agency, in which human subjects are utilized must be reviewed by the Human Subjects Review Committee. Furthermore, any proposal for such an activity must be reviewed and approved by the committee before it can be undertaken, and annually until completion.

Submit the research proposal to the Deputy Agency Director of the Health Care Agency program involved in the research. The director must sign the Research Proposal Signature form.
Download form

• Deputy Agency Director, Public Health
  Bldg. 38X
• Deputy Agency Director, Behavioral Health
  Bldg. 38X
• Deputy Agency Director, Medical Services
  Bldg. 38X

Email irb@ochca.com

An official approval form signed by the Chair of the HSRC will be sent to the primary investigator or designee. Download form

Approximately two weeks.

Annually, until the project is completed (unless otherwise specified by the HSRC).

1. Complete the HSRC Status Report form. Download form If another form is used the same information must be included:

• Name of primary investigator, title of research, project start and anticipated end date, number of subjects accrued to date and expected total number of subjects.
• Brief project summary
• Progress of the project
• Adverse events (if any) encountered in the course of the research
• Recent literature (if any) associated with research project
• Current copy of consent form and any changes made to consent form after initial approval by HSRC.
• Signature of primary investigator, (and typed name), date of signature and telephone number where investigator may be reached.

2. Provide copy of updated IRB approval if study is affiliated with a university or other external institution.

Complete the HSRC Final Report form. If another form is used the same information must be included:

• Name of primary investigator and title of research. project start and end date, and number of subjects.
• Summary of project.
• Findings/conclusions.
• Benefits derived from the study (for the subjects and in general).
• Any adverse events encountered during the course of the study. Signature of primary investigator, (and typed name), date of signature and telephone number where investigator may be reached.